Type 1 Diabetes Mellitus With Diabetic Nephropathy

Metabolic Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BioCity Biopharma
BioCity BiopharmaChina - Wuxi
1 program
1
DapagliflozinPhase 2Small Molecule1 trial
Active Trials
NCT06072326Not Yet RecruitingEst. Dec 2028

Trial Timeline

Clinical trial activity over time

2026
2027
2028
BioCity BiopharmaDapagliflozin

Clinical Trials (1)

dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Start: Jan 2026Est. completion: Dec 2028
Phase 2Not Yet Recruiting

Related Jobs in Metabolic Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space